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Abstract
Background—Physiologic adaptations occurring across successive pregnancies may increase the 
risk of adverse cardiovascular health outcomes in later life.
Methods and Results—The association between parity and metabolic syndrome (MetS) was 
examined among 7,467 Hispanic/Latina women of diverse backgrounds, aged 18–74 years, who 
participated in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) from 2008–
2011. MetS components were defined according to AHA/NHLBI criteria and included abdominal 
obesity, elevated triglycerides, low HDL cholesterol, high blood pressure, and elevated fasting 
glucose. Logistic regression models estimated odds ratios adjusting for socio-demographic, 
behavioral, and reproductive characteristics. At HCHS/SOL baseline, women reported none 
(21.1%), one (19.9%), two (25.7%), three (18.6%), four (8.8%), and five or more (5.9%) live 
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births. Compared to women with one birth, those with four births had the highest odds of 
abdominal obesity (OR=2.0, 95%CI 1.5, 2.8) and overall MetS (OR=1.4, 95%CI 1.0, 2.0) and 
those with five or more births had the highest odds of low HDL cholesterol (OR=1.5, 95%CI 1.2, 
2.0) and elevated fasting glucose (OR=1.6, 95%CI 1.1, 2.4), after adjusting for age, background, 
education, marital status, income, nativity, smoking, physical activity, menopause, oral 
contraceptive use, hormone therapy, and field center. Further adjustment for percent body fat 
attenuated these associations. No associations were observed between parity and elevated 
triglycerides or high blood pressure.
Conclusions—Higher parity is associated with an increased prevalence of selected components 
of the MetS among Hispanic/Latina women in the U.S. High parity among Hispanics/Latinas with 
a high prevalence of abdominal obesity suggests high risk for metabolic dysregulation.
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Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among women 
in the United States. In 2013, approximately 365,000 U.S. women died from heart disease 
and stroke.1 Metabolic risk factors have been identified for CVD, including abdominal 
obesity, elevated triglycerides, low high-density lipoprotein (HDL) cholesterol, high blood 
pressure, and elevated fasting glucose; a combination of three or more of these risk factors is 
known as the “metabolic syndrome” (MetS).2 The MetS is associated with an increased risk 
of adverse cardiovascular health outcomes, particularly among women.3,4
Lactation, hormonal contraceptive use, and polycystic ovary syndrome (PCOS) are factors 
unique to women that are associated with the MetS.4 Menopause and pregnancy can also 
impact the prevalence and characteristics of the MetS.4 Pregnancy, in particular, is a time 
when women experience physiological changes and are at risk of pregnancy-related 
complications, some of which are associated with a higher risk of adverse cardiovascular 
health outcomes in later life.5–8 Physiologic adaptations and complications occurring across 
successive pregnancies may be associated with an even higher risk of adverse cardiovascular 
outcomes.8 Previous studies have examined the association between parity and the MetS, but 
they have been limited by small sample sizes9–11 and study populations that were 
predominantly of non-Hispanic background.10,12–17 To our knowledge, no studies have 
examined the association between parity and the MetS in a U.S. Hispanic/Latina population.
Hispanic/Latina women have a higher prevalence of the MetS than non-Hispanic women.18 
Between 2003 and 2006, the prevalence of the MetS was approximately 41% among U.S. 
Mexican American women compared to 32% among non-Hispanic white women.18 A more 
recent estimate of the age-standardized prevalence of the MetS among Hispanic/Latina 
women from four US cities was 36% (34.6%–37.4%).19 Latinos are also the fastest-growing 
minority population in the U.S. and Hispanic/Latina women report higher fertility and birth 
rates than their non-Hispanic counterparts.20 Thus, understanding the impact of parity on the 
MetS is important for informing preventive efforts to decrease the prevalence of metabolic 
and cardiovascular disorders in this population.
Vladutiu et al. Page 2
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2017 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Our objective was to examine the association between parity and the prevalence of the five 
components of the MetS among a cohort of Hispanic/Latina women enrolled in the Hispanic 
Community Health Study/Study of Latinos (HCHS/SOL). We hypothesized that nulliparous 
(no prior live births) and multiparous (multiple live births) women would have a higher 
prevalence of each of the five components of the MetS as compared to primiparous (one live 
birth) women, with a J-shaped association expected.
METHODS
Study Population
The HCHS/SOL is a prospective, population-based cohort study of Hispanics/Latinos of 
diverse backgrounds, including individuals self-identifying as Cuban, Dominican, Mexican, 
Puerto Rican, Central American, and South American. The HCHS/SOL cohort was selected 
through a stratified multistage area probability sample in four U.S. field centers (Bronx, 
Chicago, Miami, and San Diego). Census block groups were randomly selected from 
specified areas within each community, and households were randomly selected from each 
block group. At both stages, the study oversampled areas with a high concentration of 
Hispanics/Latinos, households with a Hispanic/Latino surname, and individuals aged 45 to 
74 years. Individuals were excluded from the study if they were planning to move from the 
area within six months, unable to travel to the study site, or unable to complete the 
questionnaires. Pregnant women were asked to reschedule their visit after delivery. More 
details about the study design and methods have been previously described.21,22 This study 
was approved by the Institutional Review Boards at the Albert Einstein College of Medicine, 
Northwestern University, San Diego State University, University of Miami, and the 
University of North Carolina at Chapel Hill. Informed consent was obtained for all study 
participants.
Between 2008 and 2011, 16,415 men and women, aged 18 to 74 years, were recruited for 
participation. For this analysis, we excluded males (n=6,580). We also excluded 2,368 
women who did not meet at least one of the inclusion criteria, including those who were 
reportedly pregnant at baseline (n=14); those with missing (n=207) or implausible (n=5) 
data for parity or missing data for any of the MetS components (n=133); and those with self-
reported or diagnosed diabetes at baseline (n=2,102). Diabetics were excluded to assess the 
relationship between parity and MetS in an otherwise healthy population. The final sample 
included 7,467 women.
Baseline Examination
Participants completed a baseline clinical examination for which they were asked to fast, 
abstain from smoking for at least 12 hours, and abstain from vigorous physical activity the 
morning of the visit.22 This examination included assessments of anthropometrics, blood 
pressure, oral glucose tolerance, and several other biological measures. Weight (measured to 
the nearest 0.1kg) and height (recorded to the nearest centimeter) were obtained and waist 
circumference (recorded to the nearest centimeter) was measured. Weight and body 
composition were measured using the Tanita scale and percent body fat was provided by a 
bioelectrical impedance method. After a 5-minute rest period, three seated blood pressure 
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measurements were obtained with an automatic sphygmomanometer; the second and third 
readings were averaged and used in this analysis.
Study participants provided blood samples according to standardized protocols and samples 
were shipped to the HCHS/SOL Central Laboratory for processing. High-density lipoprotein 
cholesterol (HDL-C) was measured using a direct magnesium/dextran sulfate method and 
fasting plasma glucose was measured using a hexokinase enzymatic method (Roche 
Diagnostics, Indianapolis, Indiana). Serum triglycerides were measured on a Roche Modular 
P chemistry analyzer using a glycerol blanking enzymatic method (Roche Diagnostics). The 
assay methodologies are described in HCHS/SOL Manual 7a (available at: https://
www2.cscc.unc.edu/hchs/system/files/protocols-manuals/
UNLICOMMManual07AddendumCentralLaboratoryProceduresv1006222011.pdf).
Participants completed interviewer-administered questionnaires with information collected 
about demographics, health behaviors, and medical history. They were also asked to report 
all prescription and nonprescription medications and supplements. To overcome language 
barriers, all questionnaires were offered in English or Spanish based on the participant’s 
preference by bilingual staff who were centrally trained. All questionnaires were translated 
by a certified service using culturally sensitive translation to ensure the use of language that 
could be interpreted correctly by all Hispanic/Latino backgrounds, and pilot tested at all 
sites. Among the 7467 women included in our analysis, 80.3% (n=5,999) preferred Spanish 
questionnaires.
Measures
Parity—Parity was defined as the number of prior live births as reported by women on the 
interviewer-administered questionnaire. For this analysis, parity was categorized as: none 
(nulliparity), one, two, three, four, and five or more (grand-multiparity) prior live births. For 
secondary analyses, parity was modeled as a continuous measure.
Components of the metabolic syndrome—The components of the metabolic 
syndrome were classified according to the American Heart Association/National Heart, 
Lung, and Blood Institute 2009 Joint Scientific Statement2 and included: 1) abdominal 
obesity (waist circumference ≥88cm); 2) elevated triglycerides (≥150 mg/dL); 3) low HDL-
C (<50 mg/dL); 4) high blood pressure (≥130 mmHg systolic or ≥85 mmHg diastolic or use 
of anti-hypertension medications); and 5) elevated fasting glucose (≥100 mg/dL or use of 
anti-diabetic medications). A combination of three or more of these factors comprised the 
overall MetS.
Covariates—Women reported their age, Hispanic/Latino background, years of education 
(categorized as <12 years, 12 years, or greater than 12 years), marital status, annual 
household income (categorized as <$20,000, $20,000–$40,000, $40,000–$75,000, >
$75,000), and country of birth on the interviewer-administered questionnaire. Participants 
also reported current smoking status, physical activity (minutes per hour categorized as 
meeting the U.S. Department of Health and Human Services guidelines23 if they participated 
in the equivalent of ≥150 minutes of moderate-intensity activity or ≥75 minutes of vigorous-
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intensity activity), and reproductive history (menopausal status, history of oral contraceptive 
use, current hormone therapy).
Statistical Analysis
Descriptive analyses were conducted to examine participant characteristics by categories of 
parity at baseline. All reported means and prevalence estimates were weighted to account for 
the probability of selection and to partially adjust for differential nonresponse bias. 
Prevalence estimates of overall MetS and its components were estimated by parity using 
predicted marginals from logistic regression models and adjusted for weighted mean age in 
the analytic sample. Odds ratios (OR) and 95% confidence intervals (CI) were estimated 
from logistic regression models to assess the association between parity and MetS. Separate 
models were examined for each component of MetS and for overall MetS with several 
adjustments considered, including Model 1 (unadjusted), Model 2 (age), Model 3 (age, 
Hispanic/Latino background, education, marital status, income, nativity, smoking, physical 
activity, menopausal status, oral contraceptive use, hormone therapy, and field center), and 
Model 4 (covariates from Model 3 plus percent body fat). Model 4 was conducted to 
estimate the direct effect of parity on MetS independent of body fat because obesity is 
hypothesized to drive this association. Several coding strategies were used to assess the 
shape of the association between age and MetS. The effect of age was found to be linear for 
each component of the MetS and overall MetS, thus age was treated as a continuous variable 
for all adjusted analyses.
One prior live birth was chosen as the reference group to assess the hypothesis that there is a 
J-shaped association between parity and MetS. Women with no prior live births include 
those with a history of infertility or other reproductive issues as well as those who did not 
intend to have children. Conditions that contribute to infertility may be associated with risk 
factors for MetS, thus potentially increasing the prevalence of MetS among nulliparous 
women. Analyses were performed using SAS 9.3 software (SAS Institute, Cary, NC) or 
SUDAAN software Release 11 (RTI International, Research Triangle Park, NC).
RESULTS
Study Population
At HCHS/SOL baseline, the mean number of prior live births per woman was 1.97 (standard 
error, SE, 0.03) and ranged from 0 to 22. Women reported none (21.1%), one (19.9%), two 
(25.7%), three (18.6%), four (8.8%), and five or more (5.9%) prior live births. High 
percentages of women with five or more live births (i.e., grand multiparous women) did not 
complete high school, had a low family income, were overweight or obese, not born in the 
U.S., postmenopausal, and ever used oral contraceptives (Table). More than half of these 
women were of Mexican background (55.2%). Conversely, high percentages of women with 
one live birth completed some college, had a higher income, were normal weight, U.S. born, 
and premenopausal. Less than a third of these women were of Mexican background (31.0%). 
On average, women with five or more live births were the oldest and those with no prior live 
births were the youngest. Percent body fat, on average, was highest among those with four 
and five or more live births and lowest among those with no prior live births.
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Age-Adjusted Prevalence of MetS Components by Parity
Among women at HCHS/SOL baseline, abdominal obesity was the most prevalent MetS 
component with age-adjusted prevalence estimates ranging from 61% (standard error, SE, 
2.3) among those with no live births to 84% (SE=2.0) among those with four or more live 
births (Figure 1). Elevated fasting glucose was the least prevalent component with age-
adjusted prevalence estimates ranging from 12% (SE=1.3) among women with one live birth 
to 21% (SE=2.4) among those with five or more live births. Among the parity groups, 
women with no live births had the lowest prevalence and those with five or more live births 
had the highest prevalence of abdominal obesity, elevated triglycerides, and low HDL-C 
while adjusting for age. Similar patterns were observed for the overall MetS.
Parity and MetS Components
Compared to women with one live birth, those with four live births had the highest odds of 
abdominal obesity (OR=2.0, 95% CI 1.5, 2.8) and overall MetS (OR=1.4, 95% CI 1.0, 2.0) 
and those with five or more live births had the highest odds of low HDL-C (OR=1.5, 95% CI 
1.2, 2.0) and elevated glucose (OR=1.6, 95% CI 1.1, 2.4), after adjusting for age, Hispanic/
Latino background, education, marital status, income, nativity, smoking, physical activity, 
menopausal status, oral contraceptive use, hormone therapy, and field center (Figure 2; 
specific ORs and 95% CI for all models are located in Supplemental Table 1). Women with 
no live births had the lowest odds of abdominal obesity (OR=0.7; 95% CI 0.5, 0.9). Further 
adjustment for percent body fat attenuated the associations, including low HDL-C (OR=1.5; 
95% CI 1.1, 2.0) and elevated fasting glucose (OR=1.5, 95% CI 1.0, 2.2), and the 
associations of parity with abdominal obesity and overall MetS were no longer statistically 
significant. No associations were observed between parity and elevated triglycerides or high 
blood pressure.
When assessing parity as a continuous measure, a dose-response effect was observed 
between increasing number of live births and both abdominal obesity and low HDL-C. For 
each additional birth (i.e., an increase of one birth in the exposure measure), the estimated 
ORs of both abdominal obesity and low HDL-C were 1.1 (95% CI 1.0, 1.2) after adjusting 
for all covariates in Model 4. A dose-response effect was not observed between number of 
live births and the prevalence of elevated triglycerides, high blood pressure, elevated fasting 
glucose, or overall MetS.
To further rule out confounding by age, we conducted a sensitivity analysis restricted to 
women aged 50 years and older. The results were similar, with the exception of low HDL 
cholesterol, fasting glucose, and abdominal obesity. Women with five or more live births had 
even higher odds of low HDL cholesterol compared to those with no prior live births 
(OR=2.2; 95% CI 1.4, 3.2) and the associations between parity and fasting glucose were 
attenuated and no longer statistically significant (Supplemental Table 2). Additionally, after 
adjustment for socio-demographic, behavioral, and reproductive characteristics, women with 
no live births had higher odds of abdominal obesity than those with one live birth (OR=1.8; 
5% CI 0.9, 3.4), but the results were not statistically significant. Adjustment for percent 
body fat further attenuated this association (OR=1.3; 95% CI 0.6, 2.8).
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DISCUSSION
To our knowledge, this is the first study to examine the association between parity and MetS 
in a U.S. Hispanic/Latina population. Multi-parity was associated with an increased 
prevalence of selected components of the MetS, particularly abdominal obesity, low HDL-C 
and elevated fasting glucose, after adjustment for socio-demographic, behavioral, and 
reproductive characteristics. In contrast to our hypothesis, a linear association was observed 
between parity and both abdominal obesity and low HDL-C such that each additional live 
birth increased the odds of these MetS components by 10%. With the exception of 
abdominal obesity, these associations persisted after further adjustment for percent body fat.
Prior studies of the association between parity and individual components of the metabolic 
syndrome have conflicting results. While our results are similar to those from studies among 
Chinese and U.S. populations that found a linear association between increasing parity and 
both higher waist circumference13 and an increased prevalence of abdominal obesity (waist 
circumference >88cm),12 respectively, they are in contrast to studies of Bangladeshi17 and 
Iranian15 women where no association was observed between parity and waist 
circumference, after adjustment for similar socio-demographic, lifestyle, and reproductive 
factors. Similarly, a few prior studies also noted a linear association between increasing 
parity and lower HDL-C12,13,15 while others found no association.16,17 In contrast to our 
findings, most prior studies did not find an association between parity and elevated fasting 
glucose,12,13,17 and a few studies observed a linear association between increasing parity 
and elevated triglycerides.12,15,16 The most consistent finding across studies, including the 
present study, was the lack of association observed between parity and blood 
pressure.12,13,15,16 Overall, these results suggest that parity may alter women’s metabolic 
profiles. However, the differences in results across prior studies indicates that specific MetS 
components may be more or less susceptible to change depending on the population.
Multi-parity of four or more live births was associated with a higher prevalence of the 
overall MetS in this population of Hispanic/Latina women; as expected, this association was 
attenuated and no longer statistically significant after adjustment for percent body fat. This 
finding is consistent with prior studies among other racial and ethnic groups that observed 
significant relationships between increasing parity and overall MetS,12,13,15,16 including 
statistically significant variations by history of gestational diabetes.14 Adjustment for BMI 
attenuated these earlier findings and the associations were no longer statistically significant 
for some.12,15 These results suggest that the relationship between parity and MetS may not 
be independent of obesity, thus adiposity or weight may mediate this association.
A combination of biological changes and lifestyle factors associated with childbearing may 
explain the associations that were observed. During pregnancy, women experience 
physiological changes, such as insulin resistance, dyslipidemia, fat accumulation, 
inflammation, and weight gain.24,25 While most of these alterations revert back to the non-
pregnant state after delivery, some changes could persist and even accumulate across 
successive pregnancies.24,26,27 Additionally, changes in lifestyle risk factors (e.g., physical 
activity and stress) and the cumulative burden of caring for a larger family may impact the 
prevalence of the MetS and its components. In our study, adjustment for behavioral factors 
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simultaneously with other socio-demographic and reproductive factors attenuated the results 
slightly. Additional assessment of the association between parity and MetS among 
HCHS/SOL men could provide further insight into the role of lifestyle factors in the 
prevalence of the MetS in this population.
Etiologic mechanisms of the MetS likely differ across racial and ethnic subgroups.28 In the 
U.S., Hispanic women are disproportionately affected by the MetS18 and have a higher 
prevalence of overweight and obesity than non-Hispanic white women.29 They also have 
more children and larger families than non-Hispanics.20 Among Hispanic/Latina women in 
the HCHS/SOL Study, abdominal obesity was the most prevalent MetS component and was 
highest among women with at least four prior live births, while elevated fasting glucose was 
the least prevalent MetS component across all parity categories. High parity and a high 
prevalence of abdominal obesity among these women may suggest a context of high risk for 
metabolic dysregulation. A better characterization of the links between pregnancy, adiposity, 
and body fat distribution is needed to further assess these associations.
Strengths and limitations
Overall, this study expands upon prior studies by examining parity and MetS in a large 
Hispanic/Latina population, while also assessing this association independent of body fat. 
The strengths of this study include the large, diverse cohort recruited from HCHS/SOL field 
centers that are located in cities with large Hispanic/Latino populations, thus allowing for a 
good representation of various backgrounds among participants. This study also measured 
anthropometrics and collected detailed information on a number of biological and behavioral 
measures, including percent body fat, which to our knowledge was not collected or assessed 
in prior studies.
This study has limitations. Like most prior studies of parity and MetS, the cross-sectional 
design limits the ability to establish temporality and assess changes in biological and 
lifestyle risk factors over time. The HCHS/SOL study lacked information on pregnancy-
related complications, including diabetes and preeclampsia, which have been found to be 
associated with adverse cardiovascular health outcomes in later life7,30 and may contribute 
to the associations that were observed. Information on breastfeeding history was not 
collected in HCHS/SOL; however, breastfeeding rates among Latina women are higher than 
among other racial and ethnic groups.31 Lactation may reverse cardiometabolic adaptations 
occurring during pregnancy and fat accumulation,32,33 thus lowering the risk of metabolic 
syndrome12,34 and attenuating the association between parity and MetS.15 This study also 
lacked information on age at first live birth, which has been found to be associated with a 
decreased risk of MetS.10 There also may be additional unmeasured risk factors associated 
with multi-parity and MetS (e.g., stress). Residual confounding by these factors may have 
weakened the associations that were observed. Additionally, the generalizability of this 
study to other racial and ethnic groups may be limited.
CONCLUSION
Given the expected growth of the Hispanic/Latino population in the U.S., preventive action 
is needed to reduce metabolic and cardiovascular disease risks in this population, 
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particularly women. Our study highlights the importance of multi-parity as a potential risk 
factor for developing selected components of the MetS that can ultimately impact the risk of 
CVD in later life. The 2011 American Heart Association’s Guidelines for CVD Prevention 
in Women35 recommend obtaining information on pregnancy history when evaluating 
cardiovascular risk for women. While these guidelines highlight the importance of capturing 
a detailed history of pregnancy complications, information on the number of prior live births 
may also be informative. Early identification of high-risk women based on their pregnancy 
history provides an opportunity for both primordial and primary prevention of CVD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What is Known
• Prior studies have conflicting results, with some suggesting a linear 
association between increasing parity and an increased prevalence of 
abdominal obesity and lower HDL cholesterol, and others suggesting 
no association between parity and waist circumference or HDL 
cholesterol.
• Several prior studies found no association between parity and elevated 
fasting glucose.
What the Study Adds
• Among Hispanic/Latina women, multi-parity is associated with an 
increased prevalence of abdominal obesity, low HDL cholesterol, and 
elevated fasting glucose, after adjustment for socio-demographic, 
behavioral, and reproductive characteristics.
• Higher parity is not associated with an increased prevalence of elevated 
triglycerides or high blood pressure.
• Multi-parity is associated with an increased prevalence of the overall 
MetS, but the association may not be independent of percent body fat.
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Figure 1. 
Age-adjusted prevalence (95% CI) of MetS components by parity (N=7,467), HCHS/SOL 
Study 2008–2011. Age adjusted at 39.6 years (weighted mean age in the analytic sample). 
Abdominal obesity (waist circumference ≥88cm), elevated triglycerides (≥150 mg/dL), low 
HDL cholesterol (<50 mg/dL), high blood pressure (≥130 mmHg systolic or ≥85 mmHg 
diastolic or use of anti-hypertension medications), elevated fasting glucose (≥100 mg/dL or 
use of anti-diabetic medications), overall metabolic syndrome (a combination of 3 or more 
components).
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Figure 2. 
Adjusted odds ratios for the association between parity and components of the MetS 
(N=7,467), HCHS/SOL Study, 2008–2011. Model 2 (adjusted for age), Model 3 (adjusted 
for age, Hispanic/Latino background, education, marital status, income, nativity, smoking, 
physical activity, menopausal status, oral contraceptive use, hormone therapy, and field 
center), and Model 4 (adjusted for covariates from Model 3 plus percent body fat). 
Abdominal obesity (waist circumference ≥88cm), elevated triglycerides (≥150 mg/dL), low 
HDL cholesterol (<50 mg/dL), high blood pressure (≥130 mmHg systolic or ≥85 mmHg 
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diastolic or use of anti-hypertension medications), elevated fasting glucose (≥100 mg/dL or 
use of anti-diabetic medications), overall metabolic syndrome (a combination of 3 or more 
components).
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